BioVie Inc (BIVI) Announces Completion of Last Patient Treatment Visit in Phase 3 Trial of NE3107 in Mild to Moderate Alzheimer s Disease streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BioVie Inc (NASDAQ:BIVI) has unveiled early data from the Phase 3 study of its investigational drug NE3107 in patients with mild to moderate Alzheimer’s.